Cyramza

(ramucirumab)
10 ML ramucirumab 10 MG/ML Injection [Cyramza]50 ML ramucirumab 10 MG/ML Injection [Cyramza]
NO BLACK BOX WARNING

Dosage & administration

biomarker testing

Cyramza clinical details

Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.

drug label

Cyramza prescribing information

prior authorization

Cyramza prior authorization resources

Most recent Cyramza prior authorization forms

View By Payer
Verified: Sep 27, 2023Cigna - Cyramza Prior Authorization Form
Verified: Sep 21, 2023Aetna - Cyramza Prior Authorization Form
Verified: Sep 20, 2023Aetna - Medicare Part B Cyramza Prior Authorization Form

PDF
Complete Letter of Medical Necessity

PDF
Coverage Authorization Appeals

PDF
Coverage Authorization Appeals: Second Level

PDF
First-Level Medicare Review Letter

PDF
Second-Level Medicare Review Letter

PDF
Denied Claims Checklist
Learn More

Benefits investigation

PDF
Lilly Oncology Support Center - Infused Products Enrollment Form
Learn More

Reimbursement help (FRM)

OTHER
Receive Assistance from an FRM Regarding Reimbursement Information
Learn More

pharmacy

Cyramza preferred pharmacy

PDF
Pharmacy List

financial assistance

Cyramza financial assistance options

Co-pay savings program

commercial only

PDF
Lilly Oncology Support Center - Infused Products Enrollment Form

OTHER
Enroll in Patient Savings Program
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+

OTHER
Lilly Cares Foundation Eligibility Check
Learn More

patient education

Cyramza patient education

Getting started on Cyramza

To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

BRAND PAGE
About Cyramza: Advanced or Metastatic Gastric or GEJ Adenocarcinoma
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

BRAND PAGE
Side Effects: Advanced or Metastatic Gastric or GEJ Adenocarcinoma
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
Patient Resources: Advanced or Metastatic Gastric or GEJ Adenocarcinoma
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
NSCLC Biomarker Testing
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

BRAND PAGE
About Cymraza + Erlotinib Treatment: NSCLC
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

BRAND PAGE
About Cymraza + Docetaxel Treatment: NSCLC
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
Patient Resources: NSCLC
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

BRAND PAGE
About Cymraza Folfiri Treatment: Colorectal Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
Patient Resources: Colorectal Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

BRAND PAGE
About Cyramza: High AFP Hepatocellular Carcinoma
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
Patient Resources: High AFP Hepatocellular Carcinoma
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

Other resources

Learn More

people also ask

Cyramza FAQs

How is the dosage of Cyramza?Cyramza is available in 2 dosages, including 10 mg/ml Injection 10 ml and 10 mg/ml Injection 50 ml
What does Cyramza treat?Cyramza treats Non-Small-Cell Lung Carcinoma, Stomach Neoplasms and Colorectal Neoplasms
What is Cyramza made of?Cyramza contains ramucirumab which is a Vascular Endothelial Growth Factor Receptor 2 Antagonist
How Is Cyramza Administered?Cyramza is administered as a Injectable
What Are The Cyramza Mechanism Of Action?Cyramza mechanism of action is VEGFR2 Inhibitors
FAQ Data Source